CU6 4.66% $3.82 clarity pharmaceuticals ltd

Ann: Theranostic prostate cancer trial advances to cohort 3, page-2

  1. 6,341 Posts.
    lightbulb Created with Sketch. 1597
    This reads as good news to me. As a newbie I have a couple of questions. Appreciate if someone can help me.

    1. While the Ann is for prostrate cancer, the images shown are for lesions in the vertebra and shoulder? What’s the connection?

    2. The next phase will be dose expansion followed by phase 2?

    Thanks.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$3.82
Change
0.170(4.66%)
Mkt cap ! $1.187B
Open High Low Value Volume
$3.80 $3.88 $3.55 $10.15M 2.701M

Buyers (Bids)

No. Vol. Price($)
1 1301 $3.82
 

Sellers (Offers)

Price($) Vol. No.
$3.85 1690 1
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
$3.80
  Change
0.170 ( 3.91 %)
Open High Low Volume
$3.78 $3.87 $3.55 179402
Last updated 15.59pm 06/05/2024 ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.